MedTrace Logo

Rapid Acute Coronary Syndrome Exclusion Using High-sensitivity I Troponin

NCT04488913 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32609

Last updated 2022-03-23

No results posted yet for this study

Summary

As part of the planned implementation of a new clinical pathway using hs-cTnI, the investigators will measure patient outcomes and clinical processes in a real-world scenario throughout an integrated health system across 9 emergency departments (ED).

Conditions

Interventions

OTHER

RACE-IT Pathway

This care pathway includes the evaluation of suspected acute coronary syndrome with high-sensitivity troponin I testing and further prognostication as needed with a modified HEART score

OTHER

Standard of Care

Standard of care protocol that uses the 99th percentile troponin values for evaluation of suspected acute coronary syndrome and further prognostication using the HEART score

Sponsors & Collaborators

  • Beckman Coulter, Inc.

    collaborator INDUSTRY

  • Henry Ford Health System

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-29
Primary Completion
2021-04-03
Completion
2022-03-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04488913 on ClinicalTrials.gov